Apollo Endosurgery, Inc. (APEN) financial statements (2021 and earlier)

Company profile

Business Address 1120 SOUTH CAPITAL OF TX HWY
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36371923303523
Cash and cash equivalents36371923303523
Receivables88689911
Inventory, net of allowances, customer advances and progress billings1010111091111
Inventory1010111091111
Other undisclosed current assets4333333
Total current assets:59583944515848
Noncurrent Assets
Property, plant and equipment    777
Intangible assets, net (including goodwill)11121213131414
Goodwill5555555
Intangible assets, net (excluding goodwill)6677889
Restricted cash and investments1111111
Other noncurrent assets0333354
Other undisclosed noncurrent assets6766   
Total noncurrent assets:19222123242627
TOTAL ASSETS:77816067758475
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11111418182021
Accounts payable4371010109
Accrued liabilities777981012
Debt1853434  
Total current liabilities:12191953532021
Noncurrent Liabilities
Long-term debt and lease obligation57515219195334
Long-term debt, excluding current maturities57495119195334
Operating lease, liability 21    
Liabilities, other than long-term debt, including:2211 11
Other liabilities2      
Other undisclosed liabilities, other than long-term debt 211 11
Other undisclosed noncurrent liabilities (2)(1) 1  
Total noncurrent liabilities:59515220205435
Total liabilities:71707172727457
Stockholders' equity
Stockholders' equity attributable to parent710(11)(5)21018
Common stock0000000
Additional paid in capital277276252252251250250
Accumulated other comprehensive income3443233
Accumulated deficit(273)(269)(267)(260)(250)(243)(234)
Total stockholders' equity:710(11)(5)21018
TOTAL LIABILITIES AND EQUITY:77816067758475

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues1313611121114
Cost of revenue(6)(6)(3)(5)(6)(6)(7)
Cost of goods and services sold (6)(3)(5) (6)(7)
Gross profit:7726657
Operating expenses(10)(9)(7)(12)(13)(12)(14)
Operating loss:(3)(2)(4)(7)(7)(7)(7)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
10(1)(2)1(0)(1)
Interest and debt expense(1)(1)(1)(1)(1)(1)(1)
Loss from continuing operations before income taxes:(3)(3)(6)(10)(7)(9)(9)
Income tax expense(0)(0)(0)(0)(0)(0) 
Net loss available to common stockholders, diluted:(4)(3)(6)(10)(7)(9)(9)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(4)(3)(6)(10)(7)(9)(9)
Comprehensive loss:(4)(3)(6)(10)(7)(9)(9)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(0)12(1)01
Comprehensive loss, net of tax, attributable to parent:(4)(3)(6)(8)(8)(8)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: